Brimonidine Tartrate 0.1% 5mL

NDC: 0781-7177-75

Brimonidine Tartrate 0.1% Ophthalmic Solution, 5 mL — Sandoz

Active ingredient	Brimonidine tartrate 0.1% (1 mg/mL)
Preservative	Sodium chlorite 0.005%
Dosage form	Ophthalmic solution
Route	Topical ophthalmic
Size	5 mL
Manufacturer	Manufactured by Alcon Laboratories, Inc., Fort Worth, TX for Sandoz Inc., Princeton, NJ

Indications and Usage

Indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Dosage and Administration

One drop in the affected eye(s) three times daily, approximately 8 hours apart. If more than one topical ophthalmic product is used, administer the products at least 5 minutes apart.

Contraindications

• Neonates and infants (pediatric patients younger than 2 years old)
• Patients with a history of hypersensitivity to any component of this medication

Warnings and Precautions

• May potentiate vascular insufficiency; use with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans.
• Use with caution in patients with severe cardiovascular disease.
• May cause fatigue and/or drowsiness; caution patients engaging in hazardous activities.
• Avoid touching the dispenser tip to the eye or surrounding structures to prevent contamination and serious eye damage.

Storage

Store at 20°C to 25°C (68°F to 77°F)

Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.

If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.